Company profile: MorphoChem
1.1 - Company Overview
Company description
- Provider of innovative intravenous therapy for Clostridium difficile infection (CDI), based on novel antibacterial MCB3681, addressing an unmet medical need and aiming to make a difference for CDI patients.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to MorphoChem
ITS Innovation
HQ: United Kingdom
Website
- Description: Provider of synthetic vaccines for mutating viruses using a T-cell vaccine platform that targets conserved viral antigens to direct immune responses, and of pemvidutide, a GLP-1/glucagon dual receptor agonist for obesity and MASH, designed to reduce body weight, liver fat, serum lipids, and address liver fat and fibrosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ITS Innovation company profile →
SaNOtize
HQ: Canada
Website
- Description: Provider of platform-based nitric oxide topical therapies for upper respiratory and dermal infections, including a Nitric Oxide Nasal Spray (NONS) that reduces respiratory viral RNA load within 24–72 hours, a physician-provided Foot Cleanser for plantar warts, and a Gel Cleanser for nails and skin in development, with additional cleansers and wellness products planned for US launch in 2025–2026.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SaNOtize company profile →
Miacom Diagnostics
HQ: Germany
Website
- Description: Provider of microbiological tools for pathogen identification, manufacturing laboratory equipment, medical devices, and electrosurgery machines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Miacom Diagnostics company profile →
Aquapharm
HQ: United Kingdom
Website
- Description: Provider of drug discovery products based on the chemical diversity of marine micro-organisms, including novel pharmaceutical compounds and antibiotics for Gram negative and Gram positive infections, bio-manufactured nutraceuticals, personal care ingredients, and industrial biocatalysts. Maintains a proprietary library of over 7,000 marine micro-organisms and uses SeaRch™ technology to screen and induce production of biologically active compounds.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aquapharm company profile →
Oxsed
HQ: United Kingdom
Website
- Description: Provider of accurate and rapid testing worldwide to minimize the impact of disease on individuals and communities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oxsed company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for MorphoChem
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to MorphoChem
2.2 - Growth funds investing in similar companies to MorphoChem
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for MorphoChem
4.2 - Public trading comparable groups for MorphoChem
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →